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Abstract
Background: Epidermal homeostasis involves the monitoring of continuous proliferative and
differentiative processes as keratinocytes migrate from the basal layer to the skin surface. Recently,
differentiation of epidermal stem cells was shown to be promoted by the Notch pathway. This
pathway is characterised by cell-cell interactions between transmembrane proteins and was first
implicated in lateral inhibition, patterning and cell binary choices during embryogenesis.
Methods: By in situ hybridisation, we investigated the in vivo expression of related genes, namely;
Notch 1–3, Delta 1, Jagged 1, Lunatic Fringe, Radical Fringe and Manic Fringe during keratinocyte
proliferation and differentiation in humans in basal cell carcinoma, psoriasis and in wound healing
experiments, compared with normal adult skin.
Results: We show that the highest level of transcription of these genes is in the basal cell layer of
non-lesional skin. Conversely, when keratinocytes were hyperproliferating, as in basal cell
carcinoma, psoriasis, and during the first step of re-epithelialisation, expression was weak or non-
existent. Furthermore, normal levels of transcripts were rescued in psoriatic plaques when treated
by phototherapy, as well as in newly regenerated stratified epidermis following wound healing.
Conclusion: The Notch signalling involved in the differentiation programme of normal adult
human epidermis is altered under experimental conditions and pathologies which modify this
programme.
Introduction
In mammalian epidermis, keratinocytes progress through
successive phenotypic stages as they migrate from the ger-
minative basal layer to the skin surface. These continuous
proliferative and differentiative processes result in tissue
homeostasis. Studies on embryonic mice and rats have
shown the involvement of the Notch pathway in epider-
mal differentiation [1,2] as well as cutaneous appendage
patterning [3–5]. This, and recent work on the involve-
ment of this pathway in adults [6], allows us to assess the
transcription level of several Notch-related genes, depend-
ing on the terminal differentiation state of the keratinoc-
ytes.
The Notch system was first described as being responsible
for neurogenesis and ectodermal specification in the fruit
fly [7]. In chick and mouse embryos, it was shown to be
involved in limb bud outgrowth and somitogenesis [8].
This pathway includes Notch receptors, trans-membrane
ligands, Delta/Jagged, and Fringe proteins. By now, it has
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been demonstrated to be a cell-cell signalling implicated
in several developmental events: lateral cell inhibition,
cell fate determination, boundary formation and pattern-
ing [7,8]. In vertebrates, several molecules of the pathway
have been identified. These include (a) Notch 1–4 trans-
membrane receptors, (b) two families of transmembrane
ligands with numerous EGF repeats, Delta 1–3 and Jagged
1 and 2, and (c) three proteins modulating the ligand-re-
ceptor induced signal, termed Lunatic Fringe, Radical
Fringe and Manic Fringe. The complexity of the Notch lig-
and-receptor system suggests that a high number of com-
bined associations is necessary for multipurpose
signalling. Once the receptor is activated by a ligand from
a neighbouring cell, proteolytic cleavage results in the lib-
eration of the intracytoplasmic domain of Notch. The in-
tracytoplasmic domain is then translocated into the
nucleus, where it associates with the transcription factor
RBPJk/Su(H) to activate the expression of downstream
target genes [9]. This signalling is able to regulate cell-au-
tonomously the level of Notch partners, and to determine
the fate of neighbouring cells.
In many developing tissues, these signals inhibit differen-
tiation. However, recent data show its role in cell differen-
tiation in haematopoietic lineages, in pancreatic
progenitor cell differentiation, and neural cell outgrowth
[10–12]. In mammals, several mutations in Notch genes
leading to severe disorders have been reported. A translo-
cation which damages the Notch1 gene induces the expan-
sion of undifferentiated progenitors [13,14]. Missense
mutations, which affect the Notch3 gene, were thought to
alter the interactions with the Fringe proteins [15,16]. Mu-
tations have also been identified in mouse Notch4, which
result in the absence of a regulatory action on the extra cel-
lular domain [17] and in mammary tumorigenesis [18].
Recent work on Notch ligands confirmed that the regula-
tory action on the extra cellular domain was crucial in hu-
man adults for self-renewal and differentiation of
progenitor cells. In humans, mutation of the Jagged1 gene
induces a disorder called Alagille [19,20]. In this patholo-
gy, truncated proteins may be secreted, resulting in a dom-
inant negative effect on Notch signalling [21]. Ewing's
sarcoma may be another human malignancy in which
Notch signalling pathway is implicated, but via the inap-
propriate activation of Manic Fringe[22]. Thus, in mam-
mals, mutations in Notch genes are associated with de-
regulation of cell proliferation, differentiation and migra-
tion (for a review [23]). Furthermore, whilst our work was
in progress, Lowell et al [6] recently showed that Delta-
Notch interactions promote differentiation of epidermal
stem cells. They used transfected keratinocytes to demon-
strate that the Delta 1 ligand inhibits cell autonomously
Notch 1 receptor expression and that Delta 1 has to be
present on cells (in trans) different from those expressing
Notch 1 to trigger Notch receptor. It is a cell-cell signalling
system: clusters of stem cells expressing Delta 1 activate
transit amplifying cells which do not express Delta 1 but
express Notch 1.
Here, we evaluate the transcription levels for the trans-
membrane ligands and receptors and the Fringe mole-
cules in two clinical contexts; basal cell carcinoma (BCC)
and psoriasis, as well as in the context of experimental
wound healing, was compared with adult human non-le-
sional skin. In BCC, the most common non-melanocytic
human skin cancer [24–26], hyperplasic cell division may
lead to invasion of the dermis by epidermal tissues. Al-
though such tumours are readily treatable and usually
have a good prognosis, many can become aggressive with
local tissue invasion and destruction. There is some un-
derstanding of the elements relating to the development
of BCC, especially concerning the deregulation of Hedge-
hog signalling which is now firmly established [27]. Pso-
riasis, which affects about 2% of the Caucasian
population, is characterised by hyper proliferation and
aberrant differentiation of keratinocytes [28,29]. This dis-
ease has many features in common with wound healing
[30]. However, in the latter process, the regenerative be-
haviour of keratinocytes is transient and the epidermis re-
turns to its normal growth and differentiation programme
[31], whereas in the former the hyper proliferative behav-
iour persists.
Here we show that Notch s ignalling is as sociated with
normally differentiated human epidermis and that expres-
sion of associated transcripts are clearly repressed in the
context of cell hyper proliferation. Furthermore, this sig-
nalling pathway can be rescued by treatment in the case of
psoriasis, and reactivated when wounded epidermis is re-
paired, confirming its involvement in keratinocyte differ-
entiation.
Materials and Methods
Biological samples
Human skin was obtained from a mammary reduction
operation at the plastic surgery department of Grenoble
hospital, France. Sixteen surgical resections of basal cell
carcinoma showing various grades of proliferation and in-
vasiveness (superficial, deep nodular and infiltrative)
were provided by the dermatological departments of
Villejuif and Lyon hospitals, France. Four psoriatic pa-
tients from Grenoble gave informed consent for biopsies
to be taken. All had stable psoriatic plaques; three of them
had not been treated by systemic drugs or phototherapy in
the month preceding sampling, one of them had been
treated by phototherapy. In all these patients, biopsies
were performed on lesional and non-lesional skin so as to
obtain the epidermis. When harvested, biopsies were fro-
zen in liquid nitrogen and stored at -80°C until use.BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
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Wound healing procedure
Split-thickness (0.6 mm) human skin was grafted on con-
genitally athymic nude mice, Swiss nu/nu (Iffa Credo, Les
Oncins, France), aged 5 to 7 weeks. Mice to be grafted
were anaesthetised with pentobarbital, and a circular
piece of skin was removed from the lateral abdominal re-
gion. Skin samples to be grafted were cut into 1 cm diam-
eter pieces with a punch biopsy and fitted into the
prepared graft sites. Grafts were protected by a dressing
pad and a cohesive extensible bandage. Two months after
transplantation, animals were anaesthetised with pento-
barbital and excisional wounds were made centrally
through the entire thickness of the grafted human skin,
using a 2 mm punch. The wounds were then left exposed
to air. Seven days after the injury, the mice were eutha-
nised and the healing human graft with surrounding
mouse skin was harvested. Drs. Thélu and Favier are offi-
cially licensed by the French government to use mice for
experiments (Agreement numbers: 04017, A3851601).
Section procedure and observations
Frozen tissue specimens were orientated in OCT embed-
ding medium (Miles laboratories) and stored at -80°C. Six
to ten micrometer-thick cryostat sections were cut serially
through the specimen and were thaw-mounted onto pre-
treated slides (Super Frost plus, Menzel Gläser, Germany),
then stored at -80°C until use.
Nuclei were counter-stained during 30 min incubation in
a DNA fluorochrome solution (propidium iodide 10 µg
ml-1 in PBS), followed by three washes in PBS. Conjonc-
tive tissues and propidium iodide labelled nuclei were ex-
cited (wavelength range: 330–385 nm, WU filter,
Olympus), and blue and red fluorescence emission was
observed simultaneously. Radiolabelled riboprobes hy-
bridised to sections were detected with silver emulsion
and displayed white dots under dark field conditions.
Probes
Clones from the human EST bank were sequenced and,
when necessary, poly A+ regions were eliminated and/or
were sub cloned in pBluescript SK+ vector (Stratagen).
Gene name, clone identification number, position in the
mRNA and length are as follows: Notch 1, 700304, (3'),
0.66 kb; Notch 2, 256416, (5'), 0.73 kb; Notch 3, 261623,
(5'), 1.60 kb; Delta 1, 788147, (5'), 0.60 kb; Jagged 1,
376965, (3'), 1.10 kb; Manic Fringe, 824939, (3'), 0.58 kb;
Lunatic Fringe, 40887, (3'), 0.68 kb; Radical Fringe, C-
32410, (3'), 1.40 kb. Appropriate restriction sites and pro-
moter sites (T3 and T7) were used to transcribe antisense
mRNA probes. Three control sense mRNA probes were
synthesised using Notch 3, Jagged 1 and Lunatic Fringe plas-
mids as transcription templates.
In situ hybridisation
Transcript expression was assessed by in situ hybridisation
using (α  35S) CTP radiolabelled antisense riboprobes ac-
cording to a previously described method [32]. The hy-
bridised sections were coated with Kodak NTB-2 liquid
emulsion to reveal radiolabelling. Cold labelling was per-
formed using an antibody raised to DIG, conjugated to al-
kaline phosphatase (Roche), according to manufacturer's
instructions.
Reverse transcriptase-PCR experiments
mRNAs were extracted from human adult skin using oligo
d(T) micro columns, according to the manufacturer's pro-
tocol (Amersham, Pharmacia). Thirty or thirty-five ampli-
fication cycles were conducted at 50°C annealing
temperature using the following specific oligonucleotides:
GAPDH: AATCCCATCACCATCTTCCA and GTCATCAT-
ATTTGGCAGGTT; Lunatic Fringe: AACAAGGTGCGTCCT-
GTCCACTTC, and GTGGACGGCGTTCCGCTTGTTTTC;
Manic Fringe: CCGCGACGTCTATGTGGG, and CAGATC-
CTGGGCTTGCCA; Radical Fringe: CCCGACCTCTCGGT-
GACA, and GGTGGAAGCCTGTTCCCG; Notch1:
CACCCAGAACTGCGTGCA, and GGCAGT-
CAAAGCCGTCGA;  Notch2: GCTGATGCTGCCAAGCGT,
and CCGGGGAAGACGATCCAT; Delta1: TGCTCCTGCT-
GGCTTTCG, and TTCATAGAGGCCACCGTC; Jagged1:
GTGCATGCTCCAATCGGC, and GAAAGGCAGCACGAT-
GCG.
Results
In normal adult skin, radiolabelled antisense riboprobes
directed against Notch 1–3 mRNA hybridised to a comple-
mentary sequence in the epidermis. All three transcripts
were more strongly detected in the basal layer of interfol-
licular epidermis (Fig. 1A,1B,1C'). Radiolabelling with
Delta1 and Jagged 1 riboprobes produced a similar signal
distribution to Notch (Fig. 1D,1E'). Fringe transcripts were
all localised in the basal layer (Fig. 1G,1H,1I'). The corni-
fied layer with no cell nuclei (as detected by propidium io-
dide labelling) may bind different probes, inducing
artefacts due to edge and condensed keratin effects. In situ
hybridisation control experiments performed with three
sense mRNA probes were negative (Fig. 1F,1F' and data
not shown).
Three types of BCCs were studied: superficial, deep nodu-
lar and infiltrative. Superficial-type BCCs exhibit buds, ir-
regular proliferation of cells attached to the epidermis and
little penetration into the dermis with typical peripheral
palisading cells embedded in the dermis (Fig. 2A,2B,2C
and Fig. 3A). The expression of receptors, ligands and
Fringe were severely lowered in these regions which dis-
play uncontrolled cell proliferation (Fig. 2A',2B',2C' and
Fig. 3A). Only faint transcripts were detected in small are-BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
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Figure 1
Expression of Notch 1–3 receptors, Delta1 and Jagged1 transmembrane ligands and of the three Fringe excreted
proteins in unlesional human skin. Nuclear staining with propidium iodide (A-C, D-F, G-I) and darkfield observation of in
situ hybridisation (A'-C', D'-F', G'-I') on cryosections. Radiolabelled riboprobes against Notch (A'-C') and its ligand (D'-E') genes
are detected in the basal layer of the epidermis and to a lower extent in suprabasal layers. Fringe gene expression is restricted
to the basal layer (G'-I'). Signals detected in the upper cornified layer with no nucleated cells correspond to artefacts caused by
dense keratin and edge effects. The control (F, F') represents a skin section processed with the sense Jagged1 riboprobe under
the same conditions. Scale bar, 100 µm; Ma, Manic; Lu, Lunatic; Ra, Radical; d: dermis; bl: basal layer; spl: suprabasal layer; cl:
cornified layer; e: epidermis.BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
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Figure 2
Expression of Notch1, Jagged1 and Lunatic Fringe genes in basal cell carcinoma and in experimental wound heal-
ing. Propidium iodide nuclei counterstaining (A-C, D-F) and in situ hybridisation with radiolabelled riboprobes (A'-C', D'-F'). In
superficial basal cell carcinoma (A-C') Notch1, Jagged1 and Lunatic Fringe transcripts present a low level of expression in un-pro-
liferating epidermis (filled arrowheads), and no expression in palisading cells embedded in the dermis (empty arrowheads). In
wound healing experiments (D-F') gene expression in regenerated epidermis is lower in the middle (empty arrowheads) than
at the wound edges (filled arrowheads). Scale bar, 100 µm; d: dermis; e: epidermis; g: granulation tissue; he: hyperproliferative
epidermis; s: scab; Lu, Lunatic.BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
Page 6 of 12
(page number not for citation purposes)
as, associated with almost normal epidermal structure,
and conversely, no expression was observed in the pal-
isading cells penetrating the dermis. Deep nodular BCCs,
with tumour cell clusters of various size and shapes, and
infiltrative type, presented no palisading peripheral cells.
In these two BCC types, no expression was detected for
any of the Notch-related genes tested (Fig.
3B,3C,3D,3E,3F), even when sensitive emulsion was over-
exposed for up to 24 days. Only small areas with normal
basal layer show an expression signal.
In wound healing experiments, normal human skin was
grafted on nude mice. Then, repair of experimental exci-
sional wound [33] starts with proliferation of mouse fi-
broblastic cells, filling the wound space. These cells
created a granulocytic tissue, which was rapidly covered
with expanding keratinocytes of human epidermal origin.
Proliferating cells, which are thought to be derived from
the basal cell layer [33], migrated from the periphery to
the centre of the wound, and progressively differentiated
to constitute a pluristratified epidermis (Fig. 2D,2E,2F).
Notch-related gene expression was analysed at different
position points after injury in the newly regenerated basal
layer. In all cases, a gradation of increasing intensity from
the wound centre to the edge was evident (Fig.
2D',2E',2F'). Note also that at any given point of the
wound (e.g. open arrows in Fig. 2D',2E'), the amount of
Jagged1 mRNA amount is higher than that of Notch1 in the
adjacent slide. This suggests that Jagged1 transcript reacti-
vation occurs before those of Notch1, even though the
time delay cannot be accurately determined under the
present conditions.
Psoriatic plaques feature hyperproliferative suprabasal
layers and a thick layer of cornified cells (Fig. 4A,4B,4C).
In this case, the epidermis exhibited reduced transcription
of the tested genes (Fig. 4A',4B',4C'), compared with nor-
mal epidermis provided by the same individuals, which
were similar to normal skin (Fig. 1). The expression in ba-
sal layers was faint in some areas and absent in others.
Positive cells were located mainly at the tips of the dermal
papillae (arrowheads Fig. 4A',4B',4C'). Phototherapeutic
treatment of psoriatic plaques tissue reduced the hyper-
plasticity of the epidermis (Fig. 4D,4E,4F). In this case, hy-
bridisation analysis showed homogeneous transcription
level in the basal layer and to a relatively lesser extent in
the suprabasal layers (Fig. 4D',4E',4F'). Thus, normal skin
differentiation, rescued by the treatment, was linked to de
Figure 3
Expression of Delta-1, Notch-1 and Fringe genes in four different types of basal cell carcinoma. Nuclei (red), con-
jonctive tissues (blue) and gene expression (white) are shown simultaneously. In superficial BCCs, only few cells express Delta-
1 mRNAs in basal layer (A). The level of Notch-1 transcripts is very low in nodular BCC (B). Lu Fringe transcripts in deeply infil-
trating BCC (C) are only detected at the margin of surgical excision (arrowhead; C). The expression of the three Fringe genes
is restricted to small areas in basal layer in infiltrating BCC having a sclero-dermic differentiation (D-F). Scale bar, 100 µm; Ma,
Manic; Lu, Lunatic; Ra, Radical.BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
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Figure 4
Expression of Notch2, Jagged1 and Manic Fringe genes in untreated and phototherapy treated psoriatic skin.
Propidium iodide nuclei counterstaining (A-C, D-F) and in situ hybridisation with radiolabelled riboprobes (A'-C', D'-F'). In pso-
riatic plaques (A-C'), Notch2, Jagged1 and Manic Fringe genes are down-regulated in the basal layer, and transcripts are mainly
located at the tips of the dermal papillae (arrowheads). In psoriatic skin, treated by phototherapy (D-F'), gene expression levels
are restored to those of normal control skin (arrowheads). Scale bar, 100 µm; Ma, Manic; d: dermis; bl: basal layer; cl: cornified
layer; he: hyperproliferative epidermis.BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
Page 8 of 12
(page number not for citation purposes)
novo expression of Notch, Jagged and Fringe genes, whose
levels and patterns were similar to paired samples of
healthy skin.
Messenger RNA integrity was controlled for by using a re-
verse transcriptase-polymerase chain strategy. The house-
keeping GAPDH gene was present in every sample stud-
ied, as shown by the 558 bp fragment (Fig. 5, lane 1 to 8).
Control samples from normal skin, unaffected skin from
psoriatic patients, phototherapy treated psoriatic plaque
or normal skin obtained from the margin of surgical exci-
sion expressed Lunatic Fringe gene as shown by the 309 bp
band (Fig. 5, lane 1, 2, 4 and 8 respectively). However, the
Lunatic Fringe 309 bp fragment was not amplified after 35
cycles in psoriatic plaque and BCC biopsies samples (Fig.
5, lane 3 and 5–7, respectively). Using a non saturating
(30) number of cycle, all of the other studied genes (Rad-
ical Fringe: 300 bp, Manic Fringe: 622 bp, Notch1: 724 bp,
Notch2: 473 bp, Delta1: 301 bp, Jagged1: 509 bp) were ex-
amined by RT-PCR in four representative samples: normal
skin as positive control, psoriatic skin, infiltrating BCC
and a nodular BCC as negative control. The results are
consistent with in situ hybrisation with weak amplifica-
tion being related to weak positive areas in pathological
samples
Moreover in situ experiments on small areas of BCC as
well as fringe of wound healing experiments provided an
internal control of the studied RNA integrity (Fig 2, solid
arrowheads, Fig 3C, arrowhead).
Discussion
At the tissue resolution level, reached with radiolabelled
probes, we observe continuous labelling in the basal layer,
including putative stem cells and transit amplifying cells.
Thus in the epidermis of human adult,Notch and Delta/
Jagged ligands, as well as Fringe genes are transcribed in the
proliferating area receiving the first differentiation signals.
To a lesser extent, they are expressed in the suprabasal lay-
ers where differentiation is occurring. No major difference
between the expression pattern of Notch1–3, nor those of
Delta1/Jagged1 ligands or the Fringe genes are found, ex-
cept the latter genes are more restricted to the basal layer.
The unexpected co-localisation of the mRNA of all Notch
partners in the same tissue needs to be reconciled with re-
gards to previous data.
In human skin, Lowell et al.[6] found that Delta1 mRNA
and protein were restricted to the basal epidermal layer
while immuno-reactivity against Notch1 protein was
patchy in the basal layer and fairly strong in the supraba-
sal layer. A possible way to accomodate both data regard-
ing  Notch1 mRNA (our results) and Notch1 protein
(Lowell et al. results) would be to look for possible post-
transcriptional and/or post-translational control of pro-
tein levels leading to Notch1 protein accumulation in the
differentiating keratinocyte. In support of this explana-
tion, we found that Notch1 is still expressed by keratinoc-
ytes leaving the basal layer for the suprabasal layer.
In mouse embryo epidermis, each of the three homolo-
gous Fringe genes (Lunatic, Radical and Manic) present a
specific pattern in the basal and suprabasal layers [2], as
do Notch1 and Jagged2 in rat embryonic skin [34]. In the
embryonic mouse upper lip, Powell et al.[5] found that
Notch1, Jagged1 and Jagged2 have different expression pat-
tern, which become overlapping in the neonate, as the
hair vibrissae follicle bud is developping.
In the adult mouse, these genes are only transcribed at low
levels in interfollicular skin, detectable only by PCR [2],
and their spatial pattern has not yet been determined.
However, in cycling hair follicles of adult mice, transcripts
can be weakly detected by in situ hybridisation and display
partial overlapping patterns [3], which is reminiscent of
our present result in human.
The discrepancy between co-localisation of Notch-related
transcripts in adult skin and specific pattern in most other
systems may only be apparent, since at a cellular level, lig-
and and receptor gene expression may be cell-exclusive in
the basal layer. Some cells, or clusters of cells, could ex-
press the ligands, and neighbouring cells that express only
the Notch receptor may behave as responding cells. This
was recently demonstrated by Lowell et al. [6] for Delta 1
- Notch 1 in keratinocyte cultures and neonatal foreskin.
This creates a boundary between stem cells expressing
Delta 1 and cells committed to differentiation, which ex-
press Notch 1. We performed cold labelling of probes to
assess to cellular level in adult skin samples. Sensitivity of
this method was insufficient under our conditions to get
conclusive pictures, due to the low level of expression of
Notch related genes (data not shown). Alternatively the
co-expression of transcripts of the same group (ligand, re-
ceptor or modulator) in the same tissue and/or cells may
explain the apparent paradox that neither Notch-related
gene-targeted inactivation experiments in mice [35] nor
Notch-related human syndromes [23] produce any skin
phenotype. This co-expression of paralogous genes (at
least the 3 Notch or the 2 ligands or the 3 Fringe), would
lead to their functional redundancy in skin so that the dis-
ruption of one of these genes may be substituted by a par-
alogous one.
When keratinocytes enter into a pathological proliferation
status (BCC, psoriasis), they neither transcribe ligands nor
receptors and the differentiating signal is absent. It should
be noted that the integrity of the mRNAs was checked by
RT-PCR of several different samples extracts. A strong pos-
itive signal was obtained with GAPDH housekeepingBMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
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genes, whereas the Lunatic Fringe 309 bp fragment was not
amplified in psoriatic and BCC skin compared with con-
trols (Fig. 5). This excludes the possibility that loss of ex-
pression of Notch-related genes in diseased tissue samples
is due to loss of RNA integrity. This observation is
strengthened by the results obtained for the expression at
the excision margin (Fig. 3C) and at the localised region
of basal layer (Fig. 3A,3D,3E) which provide a control. Af-
ter phototherapy of psoriatic skin, expression of Notch-re-
lated genes is restored and partial differentiation of
keratinocytes occurred. During healing, a rapid but tem-
porary proliferation status of keratinocytes is required to
cover the newly constituted granulocytic layer, and they
no longer express ligands, nor receptor transcripts. Tran-
scription is then progressively activated when the epider-
mis starts to become stratified and differentiated.
We show by observation of skin pathologies (BCC, psoria-
sis), course of treatment (phototherapy) and by using in
vivo experimentation (wound healing), that Delta/Notch
signalling is decreased in uncontrolled proliferating con-
ditions and conversely, it is triggered as soon as cells are
committed to a differentiation programme. We have also
shown previously that in anagen vibrissa follicle of adult
Figure 5
Notch -related gene expression is down-regulated in psoriatic and in BCC skin biopsies. Using RT-PCR, the ampli-
fication rate of a 309 bp fragment from Lunatic Fringe cDNA was compared with that of a 558 bp fragment of GAPDH used as
an internal control. One unaffected and three lesional skin cDNA samples were amplified by PCR looking for the following
fragments: (Radical Fringe: 300 bp, Manic Fringe: 622 bp, Notch1: 724 bp, Notch2: 473 bp, Delta1: 301 bp, Jagged1: 509 bp). Sample
1: normal human skin; sample 2: skin from an unaffected region of a psoriatic patient; sample 3: psoriatic skin from the same
patient; sample 4: psoriatic skin, treated by phototherapy; sample 5 : infiltrating BCC (see Fig. 3C); sample 6: nodular BCC (see
Fig. 3B); sample 7:infiltrating BCC (see Fig. 3D,3E,3F); sample 8: unaffected skin surrounding the excised BCC region (see left
side of Fig. 3C).BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/7
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mice where different cell fates are to be determined for ke-
ratinocytes, Notch-1, Lunatic and Manic Fringe genes are
expressed in specific layers of the outer root sheath. In the
catagen phase, when ill-defined and largely undifferenti-
ated keratinocytes fill the follicle, there is no expression of
Lunatic and Manic Fringe genes, and Notch-1 has a diffuse
expression pattern. Hence, in vivo observations, which are
at tissue resolution, corroborate in vitro results showing
that in the epidermis, Notch signalling promotes differen-
tiation of receiving cells [6]. Nevertheless, compared with
many other situations, this link between Notch and differ-
entiation appears paradoxal, i.e. mutations in Notch 1, 2,
4[13,14,17] or in Jagged1[36,37] genes inducing constitu-
tive Notch activation mediate proliferation of undifferen-
tiated progenitor blood cells or mammary
tumourigenesis. Therefore, this pathway may have the op-
posite effect depending on the cell type concerned and the
tissue environment.
In fact, Notch signalling controls cell choices in both in-
vertebrates and vertebrates [7] by inhibiting certain differ-
entiation pathways, thereby permitting cells to either
differentiate to an alternative pathway or to self-renew.
Feed-back in the Notch pathway amplifies weak stochastic
bias between adjacent cells so that even a subtle variation
in the amount of signal would generate drastically distinct
cell fate. In the epidermal basal layer, Notch receptors are
present in transit amplifying cells [6] and the cell-cell sig-
nalling system promotes both expansion and differentia-
tion of these cells. Our results are consistent with the
possibility that contact-dependent Notch-ligand interac-
tions among neighbouring basal layer cells mutually con-
trol their proliferation and initiate their differentiation. In
other words, low Notch activity or even none may be per-
missive for over-growth of poorly differentiated cells,
whereas high Notch activity would be expected to control
growth and undergo a change of cells fate. Similarly, re-
cent studies have shown that members of the Notch sig-
nalling pathway affect neurite outgrowth and neuronal
differentiation [12]. Notch/Delta is also critical for the de-
cision between the endocrine and exocrine fates in devel-
oping pancreas [10]. It has been shown that despite their
endodermal origin, pancreatic cells share several molecu-
lar characteristics with neurones. Our results are also con-
sistent with the observation of reactivation of Notch and
Delta 1 during cell differentiation consecutive to injury of
mouse dental pulp [38].
The broad down-regulation of Notch-related genes expres-
sion in diseased skin raised the question as to whether this
phenomenon occurs with other mRNAs. A broad-scale
evaluation of gene expression has been reported in scar
tissue compared with normal skin using a cDNA microar-
ray of 4 000 genes without indication whether Notch-re-
lated genes were included [39]. Data indicate that 142
genes were over expressed compared with uninjured skin,
while 50 were downregulated. Another experimental
model comparing psoriatic-involved skin and normal
control skin by a differential display strategy showed
around 60 cDNA species to be specifically displayed in
psoriasis [40], but downregulated genes were not the fo-
cus of this approach. To our knowledge, no extensive
studies have been published concerning transcriptome
behaviour in the case of BCCs compared with normal
control skin or paired adjacent skin. This is probably be-
cause BCC have been shown to be associated with muta-
tions that activate the proto-oncogene Smoothened
(SMO) or that inactivate the tumour suppressor Patched
(PTCH), both involved in the Hedgehog (Hh) pathway.
Therefore, BCC is known to be initiated by constitutive ac-
tivation of Hedgehog-responsive genes [27], excluding
Notch dysfunction as the initial event. Therefore, the sub-
sequent involvement of Notch in this disorder remains to
be investigated. Numerous proto-oncogenes, cytokines
and signalling molecule mRNA expression have been re-
cently evaluated by hybridisation [40–44], Together, these
studies show that the down-regulation of Notch/Delta
genes cannot account for a global down-regulation of
most mRNA synthesis following skin injury or disease.
However, as yet only little is known concerning the
Notch/Delta pathway in skin disorders. Interestingly,
Manic Fringe maps in the region of two cancer-associated
loci and Radical Fringe maps close to a familial psoriasis
susceptibility locus [45].
Conclusions
We show here that Delta, Notch and Fringe signalling
molecules are up-regulated in the basal and differentiat-
ing layers of adult human epidermis, whereas they are un-
der-expressed in disorganised proliferating epidermis. We
postulate that the specific differentiation programme that
keratinocytes undergo in skin is under their control. We
suggest that alteration of the Notch pathway may some-
how play a role in disrupting the keratinocyte differentia-
tion programme, leading to unorganised suprabasal
epidermal strata and/or dermal invasion. In the cases
studied here, it remains to be definitively established
whether their transcription is a cause rather than a conse-
quence of commitment to epidermal differentiation.
Abbreviations
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